294 related articles for article (PubMed ID: 18083549)
1. Virus-like particles-universal molecular toolboxes.
Ludwig C; Wagner R
Curr Opin Biotechnol; 2007 Dec; 18(6):537-45. PubMed ID: 18083549
[TBL] [Abstract][Full Text] [Related]
2. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
Mohsen MO; Zha L; Cabral-Miranda G; Bachmann MF
Semin Immunol; 2017 Dec; 34():123-132. PubMed ID: 28887001
[TBL] [Abstract][Full Text] [Related]
3. Design of novel vaccines based on virus-like particles or chimeric virions.
Bárcena J; Blanco E
Subcell Biochem; 2013; 68():631-65. PubMed ID: 23737067
[TBL] [Abstract][Full Text] [Related]
4. A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles.
Tang S; Xuan B; Ye X; Huang Z; Qian Z
Sci Rep; 2016 May; 6():25741. PubMed ID: 27170066
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Pinto LA; Edwards J; Castle PE; Harro CD; Lowy DR; Schiller JT; Wallace D; Kopp W; Adelsberger JW; Baseler MW; Berzofsky JA; Hildesheim A
J Infect Dis; 2003 Jul; 188(2):327-38. PubMed ID: 12854090
[TBL] [Abstract][Full Text] [Related]
6. Designing Chimeric Virus-like Particle-based Vaccines for Human Papillomavirus and HIV: Lessons Learned.
Eto Y; Saubi N; Ferrer P; Joseph J
AIDS Rev; 2019; 21(4):218-232. PubMed ID: 31834327
[TBL] [Abstract][Full Text] [Related]
7. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
8. Recent advancements in combination subunit vaccine development.
Tan M; Jiang X
Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319
[TBL] [Abstract][Full Text] [Related]
9. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
10. Papillomavirus-like particle vaccines.
Schiller JT; Lowy DR
J Natl Cancer Inst Monogr; 2001; (28):50-4. PubMed ID: 11158207
[TBL] [Abstract][Full Text] [Related]
11. Papillomavirus-like particles and HPV vaccine development.
Schiller JT; Lowy DR
Semin Cancer Biol; 1996 Dec; 7(6):373-82. PubMed ID: 9284529
[TBL] [Abstract][Full Text] [Related]
12. Current status and future directions of fish vaccines employing virus-like particles.
Jeong KH; Kim HJ; Kim HJ
Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
[TBL] [Abstract][Full Text] [Related]
13. Virus-like particles: flexible platforms for vaccine development.
Chackerian B
Expert Rev Vaccines; 2007 Jun; 6(3):381-90. PubMed ID: 17542753
[TBL] [Abstract][Full Text] [Related]
14. Immunological analyses of human papillomavirus capsids.
Giroglou T; Sapp M; Lane C; Fligge C; Christensen ND; Streeck RE; Rose RC
Vaccine; 2001 Feb; 19(13-14):1783-93. PubMed ID: 11166904
[TBL] [Abstract][Full Text] [Related]
15. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
16. Virus-like particle-based vaccines against hepatitis C virus infection.
Bellier B; Klatzmann D
Expert Rev Vaccines; 2013 Feb; 12(2):143-54. PubMed ID: 23414406
[TBL] [Abstract][Full Text] [Related]
17. Virus-like particles: passport to immune recognition.
Grgacic EV; Anderson DA
Methods; 2006 Sep; 40(1):60-5. PubMed ID: 16997714
[TBL] [Abstract][Full Text] [Related]
18. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.
Masavuli MG; Wijesundara DK; Torresi J; Gowans EJ; Grubor-Bauk B
Front Microbiol; 2017; 8():2413. PubMed ID: 29259601
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
